Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis | 2024 | JAMA Cardiology |
Comparison of efficacy and safety of sarpogrelate-based anti-platelet therapy with non-sarpogrelate-based anti-platelet therapy following arterial endovascular therapy: a systematic review | 2024 | Annals of Medicine and Surgery |
Clopidogrel Versus Aspirin as Monotherapy Following Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Receiving a Drug-Eluting Stent: A Systematic Literature Review and Meta-Analysis | 2024 | Clinical Cardiology |
Efficacy and safety of aspirin plus clopidogrel versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: A meta-analysis of randomized controlled trials | 2024 | Vascular Medicine (London, England) |
Antiplatelet Resistance in Coronary Artery Bypass Grafting: A Systematic Review | 2024 | Surgery Research and Practice |
Potent P2Y(12) Inhibitor Selection and De-escalation Strategies in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: Systematic Review and Meta-analysis | 2024 | CJC Open |
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis | 2024 | European Heart Journal |
Comparison of clopidogrel and ticagrelor in treating acute coronary syndrome undergoing PCI: A systematic review and meta-analysis | 2024 | Heliyon |
Comprehensive comparative efficacy and safety of potent P2Y(12) inhibitors in patients undergoing coronary intervention: A systematic review and meta-analysis | 2024 | International Journal of Cardiology |
Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis | 2024 | Cardiology Journal |
Efficacy and Safety Profile of Ticagrelor Versus Clopidogrel in Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome (ACS): A Systematic Review and Meta-Analysis | 2023 | Cureus |
The effect of ticagrelor on coronary microvascular function after PCI in patients with ACS compared to clopidogrel: A systematic review and meta-analysis | 2023 | PLoS One |
Lower Plasma miR-223 Level Is Associated with Clopidogrel Resistance in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis | 2023 | Journal of Interventional Cardiology |
Effect of pretreatment with a P2Y(12) inhibitor in patients with non-ST-elevation acute coronary syndrome: a systematic review and network meta-analysis | 2023 | Frontiers in Cardiovascular Medicine |
P2Y(12) Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events | 2023 | Journal of the American College of Cardiology |
Antithrombotic regimens for the prevention of major adverse cardiac events in chronic coronary syndrome: A systematic review and network meta-analysis | 2023 | Frontiers in Cardiovascular Medicine |
Hypoglycemia as a potential risk for patients taking clopidogrel: A systematic review and meta-analysis | 2023 | Frontiers in Endocrinology |
Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis | 2023 | American Journal of Cardiovascular Drugs |
Clopidogrel Vs Aspirin Monotherapy Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis | 2023 | Current Problems in Cardiology |
Efficacy and safety outcomes of long-term anti-thrombotic treatment of chronic coronary artery disease: A systematic review and network meta-analysis | 2022 | Frontiers in Cardiovascular Medicine |
Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials | 2022 | Frontiers in Pharmacology |
Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis | 2022 | Drugs |
CYP2C19 polymorphism and coronary in-stent restenosis: A systematic review and meta-analysis | 2022 | F1000 Research |
Antiplatelet agents and anticoagulants for hypertension | 2022 | The Cochrane Database of Systematic Reviews |
Clinical Efficacy and Safety of Reduced-Dose Prasugrel versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | 2022 | Acta Cardiologica Sinica |
P2Y12 inhibitor pretreatment in patients with nonST-segment elevation acute coronary syndrome: A meta-analysis | 2022 | Medicine |
Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review | 2022 | European Journal of Clinical Pharmacology |
Early vs. Delayed Initiation of Treatment With P2Y(12) Inhibitors in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials | 2022 | Frontiers in Cardiovascular Medicine |
High-Dose Clopidogrel versus Ticagrelor in CYP2C19 intermediate or poor metabolizers after percutaneous coronary intervention: A Meta-Analysis of Randomized Trials | 2022 | Journal of Clinical Pharmacy and Therapeutics |
Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines | 2022 | Stroke and Vascular Neurology |
P2Y12 inhibitors plus aspirin for acute treatment and secondary prevention in minor stroke and high-risk transient ischemic attack: A systematic review and meta-analysis | 2022 | European Journal of Internal Medicine |
Antiplatelet agents for chronic kidney disease | 2022 | The Cochrane Database of Systematic Reviews |
Platelet Biomarkers in Patients with Atherosclerotic Extracranial Carotid Artery Stenosis: A Systematic Review | 2022 | European Journal of Vascular and Endovascular Surgery |
A Systematic Review and Meta-Analysis on the Impact of High On-Treatment Platelet Reactivity on Clinical Outcomes for Patients Taking ADP Receptor Inhibitors Following Lower Limb Arterial Endovascular Intervention | 2022 | European Journal of Vascular and Endovascular Surgery |
Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease | 2022 | Current Medical Research and Opinion |
P2Y12 receptor inhibitor plus aspirin versus aspirin treated within 24 hours of acute noncardioembolic ischemic stroke or TIA: Meta-analysis | 2022 | Journal of the Formosan Medical Association |
Aspirin Alone Versus Dual Antiplatelet Therapy after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis | 2022 | Cardiovascular Drugs and Therapy |
Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials | 2022 | Clinical Research in Cardiology |
The Effect of Ticagrelor on Endothelial Function Compared to Prasugrel, Clopidogrel, and Placebo: A Systematic Review and Meta-Analysis | 2021 | Frontiers in Cardiovascular Medicine |
Comparison of Safety and Efficacy Between Clopidogrel and Ticagrelor in Elderly Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis | 2021 | Frontiers in Pharmacology |
Network Meta-analysis of the Benefit of Aspirin with Rivaroxaban vs. Clopidogrel for Patients with Stable Symptomatic Lower Extremity Arterial Disease | 2021 | European Journal of Vascular and Endovascular Surgery |
De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes | 2021 | Journal of the American College of Cardiology |
Dual Antiplatelet Therapy vs. Single Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: An Updated Systematic Review and Meta-Analysis | 2021 | Frontiers in Cardiovascular Medicine |
Efficacy and Safety of Aspirin Combined with Low-Dose P2Y12 Receptor Antagonists in East Asian Patients Undergoing PCI | 2021 | International Heart Journal |
Antiplatelet therapy after transcatheter aortic valve implantation: a systematic review and meta-analysis | 2021 | European Journal of Cardio-Thoracic Surgery |
P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack | 2021 | Stroke |
P2Y12 Antiplatelet Choice for Patients with Chronic Kidney Disease and Acute Coronary Syndrome: A Systematic Review and Meta-Analysis | 2021 | Journal of Personalized Medicine |
Reduced-Dose Prasugrel versus Clopidogrel for Patients Undergoing Percutaneous Coronary Intervention | 2021 | International Heart Journal |
Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis | 2021 | Cardiovascular Drugs and Therapy |
Ticagrelor as compared to conventional antiplatelet agents in coronary artery disease: A comprehensive meta-analysis of 15 randomized trials | 2021 | Vascular Pharmacology |
P2Y(12) inhibitor monotherapy and dual antiplatelet therapy after percutaneous coronary intervention: An updated meta-analysis of randomized trials | 2021 | Thrombosis Research |
Pharmacodynamic and clinical efficacy of reduced ticagrelor maintenance doses in patients with coronary artery disease | 2021 | Current Medical Research and Opinion |
Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis | 2021 | Current Vascular Pharmacology |
Very short dual antiplatelet therapy after PCI and new DES: a meta-analysis of 5 randomized trials | 2021 | Revista Espanola De Cardiologia (English Ed.) |
Effects of the ABCB1 C3435T single nucleotide polymorphism on major adverse cardiovascular events in acute coronary syndrome or coronary artery disease patients undergoing percutaneous coronary intervention and treated with clopidogrel: A systematic review and meta-analysis | 2020 | Expert Opinion On Drug Safety |
Efficacy and safety of newer P2Y(12) inhibitors for acute coronary syndrome: a network meta-analysis | 2020 | Scientific Reports |
Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials | 2020 | Cardiovascular Therapeutics |
Efficacy and safety of low dose ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis | 2020 | Postgraduate Medical Journal |
Comparative Efficacy and Safety of Oral P2Y(12) Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials | 2020 | Circulation |
Efficacy and safety of clopidogrel versus prasugrel and ticagrelor for coronary artery disease treatment in patients with CYP2C19 LoF alleles: a systemic review and meta-analysis | 2020 | British Journal of Clinical Pharmacology |
Long-term effect of clopidogrel in patients with and without diabetes: A systematic review and meta-analysis of randomized controlled trials | 2020 | World Journal of Diabetes |
Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis | 2020 | European Heart Journal |
De-escalation versus standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis | 2020 | Platelets |
Cilostazol Mono and Combination Treatments in Ischemic Stroke: An Updated Systematic Review and Meta-Analysis | 2019 | Stroke |
Ticagrelor after pharmacological thrombolysis in patients with ST-segment elevation myocardial infarctions: insight from a trial sequential analysis | 2019 | Journal of Thrombosis and Thrombolysis |